On the other hand, patients with immune-mediated TTP (iTTP) have anti-ADAMTS13 inhibitors that counteract the ADAMTS13 function, leaving VWF polymers uncleaved. This evidence concerns the gene ADAMTS13 and thrombotic thrombocytopenic purpura.